Your browser doesn't support javascript.
loading
The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Nguyen-Them, Ludovic; Costopoulos, Myrto; Tanguy, Marie-Laure; Houillier, Caroline; Choquet, Sylvain; Benanni, Hind; Elias-Shamieh, Rwaida; Armand, Marine; Faivre, Geraldine; Glaisner, Sylvie; Malak, Sandra; Vargaftig, Jacques; Hoang-Xuan, Khê; Ahle, Guido; Touitou, Valérie; Cassoux, Nathalie; Davi, Frédéric; Merle-Béral, Hélène; Le Garff-Tavernier, Magali; Soussain, Carole.
Afiliação
  • Nguyen-Them L; Groupe Hospitalier Pitié-Salpétrière, Neuro-oncology, Paris, France.
  • Costopoulos M; Groupe Hospitalier Pitié-Salpétrière, Biological Hematology, Paris, France; Paris University Sorbonne UPMC, INSERM UMRS 1138, France.
  • Tanguy ML; Groupe Hospitalier Pitié-Salpétrière, Biostatistics, Paris, France.
  • Houillier C; Groupe Hospitalier Pitié-Salpétrière, Neuro-oncology, Paris, France.
  • Choquet S; Groupe Hospitalier Pitié-Salpétrière, Hematology, Paris, France.
  • Benanni H; Hôpital René Huguenin, Institut Curie, Biological Hematology, Saint-Cloud, France.
  • Elias-Shamieh R; Hôpital René Huguenin, Institut Curie, Hematology, Saint-Cloud, France.
  • Armand M; Groupe Hospitalier Pitié-Salpétrière, Biological Hematology, Paris, France.
  • Faivre G; Groupe Hospitalier Pitié-Salpétrière, Neuro-oncology, Paris, France.
  • Glaisner S; Hôpital René Huguenin, Institut Curie, Hematology, Saint-Cloud, France.
  • Malak S; Hôpital René Huguenin, Institut Curie, Hematology, Saint-Cloud, France.
  • Vargaftig J; Hôpital René Huguenin, Institut Curie, Hematology, Saint-Cloud, France.
  • Hoang-Xuan K; Groupe Hospitalier Pitié-Salpétrière, Neuro-oncology, Paris, France; Paris University Sorbonne UPMC, INSERM U1127, CNRS UMR 7225, IHU, ICM, France.
  • Ahle G; Hôpitaux Civils de Colmar, Neurology, Colmar, France.
  • Touitou V; Groupe Hospitalier Pitié-Salpétrière, Ophthalmology, Paris, France.
  • Cassoux N; Hôpital Claudius Regaud, Institut Curie, Ophthalmology, Paris, France.
  • Davi F; Groupe Hospitalier Pitié-Salpétrière, Biological Hematology, Paris, France.
  • Merle-Béral H; Groupe Hospitalier Pitié-Salpétrière, Biological Hematology, Paris, France.
  • Le Garff-Tavernier M; Groupe Hospitalier Pitié-Salpétrière, Biological Hematology, Paris, France.
  • Soussain C; Hôpital René Huguenin, Institut Curie, Hematology, Saint-Cloud, France; Collège de France, INSERM U1050, CNRS UMR 7241, Paris, France. Electronic address: carole.soussain@curie.fr.
Eur J Cancer ; 61: 69-76, 2016 07.
Article em En | MEDLINE | ID: mdl-27156226
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Interleucina-10 / Neoplasias do Sistema Nervoso Central Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Interleucina-10 / Neoplasias do Sistema Nervoso Central Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article